Prelude Capital Management, LLC Lyra Therapeutics, Inc. Transaction History
Prelude Capital Management, LLC
- $1.39 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding LYRA
# of Institutions
53Shares Held
31.6MCall Options Held
316KPut Options Held
600-
Perceptive Advisors LLC New York, NY12.8MShares$3.19 Million0.1% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.77MShares$1.19 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$707,4940.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA2.78MShares$695,0650.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.73MShares$432,7280.0% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $7.96M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...